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A straightforward, high throughput method was developed and fully validated for the simultaneous 
determination of the specific tobacco biomarkers nicotine and its main metabolite cotinine in a wide 
dynamic range and supporting the most common human biological matrices (urine, oral fluid and 
hair).  Sample preparation was performed inside the very HPLC injection vials by pipetting 0.5 mL 
of the liquid samples, deuterated internal standards in alkaline solution and dichloromethane as 
extraction solvent. Solid samples (i.e. around 10 mg hair) were first submitted to alkaline digestion 
in the HPLC vials and processed accordingly. The organic phase (reached through the upper 
aqueous layer) was directly injected without further treatment. Instrumental analysis was performed 
using hydrophilic interaction (HILIC) ultra-high performance liquid chromatography-tandem mass 
spectrometry (UHPLC-MS/MS). Total chromatographic time was 2 min. The method covers a wide 
dynamic range making it fit-for-purpose for the analysis of samples covering entire populations, 
irrespective of the level of exposure or tobacco use. Calibration curves (r2>0.995) covered the 
range 1-2,000 ng/mL (or 0.05-100 ng/mg hair) for nicotine and 0.1-2,000 ng/mL (or 0.005-100 
ng/mg hair) for cotinine. Within-run and between-run precision and accuracy were typically below 
10%, and always below 20% at the lower limit of quantification. The method was successfully 







Tobacco consumption is the leading cause of cancer death worldwide. It may also be the origin of 
cardiovascular and respiratory diseases, including acute myocardial infarction and chronic 
obstructive pulmonary disease [1]. Passive exposure to second hand smoke (SHS) also increases 
the risk of lung cancer and acute myocardial infarction in non-smokers [2]. The ratification of the 
WHO Framework Convention on Tobacco Control [3] requires all signatory countries to adopt and 
implement effective legislative measures to protect the population from exposure to tobacco smoke 
in indoor workplaces, public transport, indoor public places and, as appropriate, other public 
places. As a consequence, smoke-free laws have regulated the places where tobacco products 
can be used [4]. There is an increasing interest in monitoring the use of tobacco products and the 
exposure to SHS in larger number of samples, encompassing whole populations.  Lower 
concentrations were also expected as non-smokers became the target of many studies [5]. Using 
biomarkers to get a quantitative measurement of the real exposure to tobacco smoke is very 
relevant and much more accurate than self-reported data of the perceived exposure obtained 
through questionnaires [6-8].  
 Nicotine and its main metabolite cotinine have been extensively used as specific markers of 
tobacco exposure. Depending on the aim of the study, different matrices have been chosen, being 
the non-invasive, e.g. urine, oral fluid and hair the most widely analysed [9]. 
 Cotinine, with a half-life of 7-40 h, is the preferred biomarker in urine and oral fluid. Nicotine 
is found in much lower concentrations and has a much shorter half-life of 2-3 h. Urine and oral fluid 
concentrations give a good indication of the exposure in the 3 or 4 days prior to sample collection 
[10]. 
 Hair grows approx. 1 cm per month, on average. Segmental analysis allows measuring the 
level of exposure along months, depending on the length of the hair shaft obtained [11, 12]. 





 Fast and straightforward quantification of nicotine and cotinine in multiple biological matrices 
is needed. Furthermore, procedures should be applicable to a wide range of concentrations 
covering samples from heavy smokers to non-smokers or even newborns with little exposure [14]. 
 There is abundant literature on the measurement of nicotine and cotinine in different 
biological matrices ranging from radioimmunoassays [10, 15] to gas and/or liquid chromatography 
methods, with a wide variety of detectors [16-23]. In the last years, tandem mass spectrometry has 
become the detection system of choice [14, 17, 18, 24-28]. 
 Sample preparation procedures using either solid-phase extraction or liquid-liquid extraction 
have been described with varying complexity depending on the selectivity and type of instrumental 
system used. Limits of quantification (LOQ) as low as 0.02 ng/mL of cotinine in oral fluid or urine 
[5, 29] and 0.04 ng/mg of nicotine in hair [30] have been described. However, all procedures 
required steps that were throughput bottlenecks. A new approach was required to reach a balance 
between the easiest sample preparation for most biological matrices and compatibility with 
chromatographic conditions and instrumental sensitivity. 
 The aim of the present work was the development of a high-throughput quantitative 
procedure for the most commonly used tobacco biomarkers (i.e. nicotine and cotinine), applicable 





(−)-Nicotine and (−)-cotinine 1.0 mg/mL standard solutions in methanol as well as HPLC grade of 
formic acid were purchased from Fluka-Sigma-Aldrich (Madrid, Spain). (±)-nicotine-d4 (2,4,5,6-
tetradeutero-3-(1-methylpyrrolidin-2-yl)-pyridine) 100 μg/mL solution in acetonitrile and (±)-cotinine-
d3 (5-(3-pyridinyl)-1-trideuterometyl-2-pyrrolidinone) 1.0 mg/mL in methanol, were purchased from 
Cerilliant Corp (Round Rock, Texas, USA). HPLC grade methanol and acetonitrile, as well as 
analytical grade sodium hydroxide, potassium chloride and ammonia solution 25% were obtained 




Scharlau (Barcelona, Spain). Ultrapure water was obtained from a Millipore Milli-Q water 
purification system. 
 
Biological sample collection 
Human blank specimens (urine, oral fluid and hair) for the development and validation of the 
method were obtained from healthy donors at IMIM (Hospital del Mar Medical Research Institute), 
Barcelona (Spain). Oral fluid specimens were collected as part of a cross-sectional study [25, 31, 
32] in partnership with the Catalan institute of Oncology (ICO). It was a representative sample of 
the general population of Barcelona (Spain) (n=1,245) consisting of smokers and non-smokers 
exposed to SHS. Urine plus oral fluid and hair samples (n=49 each) were also collected from a 
convenience sample [33] (funded by Instituto de Salud Carlos III-FEDER, Government of Spain, 
grants PI081339 and PI081436). Finally, hair samples were also collected from different cohorts of 
newborn and infants (n=629) with smoker parents (a project from the Spanish National Committee 
on Smoking Prevention, grant CNPT0701) [34]. Hair was collected from the vertex posterior where 
possible. Protocols were approved by the respective Local Ethics Committees and all participants 
provided written informed consent. Oral fluid samples were collected by spontaneous generation 
helped by sucking a lemon candy (Smint). Liquid matrices were kept at -20ºC. Hair samples were 
cut close to the scalp, and kept in individual envelopes at room temperature with both ends 
(proximal and distal) identified. 
 
Preparation of standard solutions 
Nicotine and cotinine 1.0 mg/mL solutions were used, as purchased, as primary stock solutions. 
Separate working solutions (calibration curve and quality controls from different product batches) 
were prepared by proper dilutions in acetonitrile at concentrations of 0.1, 1, 10 and 100 µg/mL for 
nicotine and 0.01, 0.1, 1, 10, 100 µg/mL for cotinine. All stock and working solutions were stored at 






Preparation of internal standard solutions 
For nicotine-d4, the purchased 100 μg/mL solution was used as stock solution. For cotinine-d3, a 
100 µg/mL solution was prepared as stock solution by diluting 10 times the original 1 mg/mL 
solution with acetonitrile. 
 Two different internal standard (IS) working solutions containing both substances were 
prepared. For the analysis of liquid matrices (urine, oral fluid or water) 250 μL of the nicotine-d4 
plus 25 μL of the cotinine-d3 stock solutions were diluted to 250 mL with a NaOH 1M, KCl 2M 
aqueous solution. For hair analysis, a further six-fold dilution of the previous solution was used. 
These working solutions were kept at 4ºC in an amber bottle and could be used for up to 3 months. 
 
Sample preparation 
In an HPLC injection vial (high recovery conical bottom 1.5 mL, Agilent ref. no. 5184-3551), 0.5 mL 
aliquot of a liquid sample (urine, centrifuged oral fluid or water),  0.1 mL of the corresponding IS 
working solution (see above) and 0.5 mL dichloromethane were added. Vials were crimped, placed 
in a rocking mixer for 15 min at a frequency of 50 min-1 and centrifuged at 3400xg for 10 min. Hair 
samples were first washed (three times with dichloromethane by sonication for 10 min). After 
drying at a temperature below 40ºC, the segment to be analysed was put in a flat bottomed plastic 
tubes (50 x 16mm), finely cut with scissors and kept at room temperature until analysis. In an 
HPLC injection vial, an amount of approx. 10 mg was directly weighed and 0.6 mL of the 
corresponding IS working solution added. Vials were crimped and kept for 30 min at 80 ºC in a dry 
block. The resulting digested samples were extracted as the liquid matrices above. Vials were 
stored at -20ºC until analysis. 
 
Liquid chromatography-tandem mass spectrometry 
Analyses were performed on an Agilent Technologies LC 1200 series HPLC system connected to 
an Agilent 6410 triple quadrupole mass spectrometer, through an electrospray ionization source 
working in positive ionization mode. Chromatographic separation was achieved using an ultra-rapid 




2,1 mm I.D. 130 Å pore, 1.7 μm particle size. The column temperature was kept at 35 ºC. The 
needle of the injector was externally rinsed with methanol/water (1:1) for 10 s prior to each 
injection. A volume of 10 µL of the organic layer of each extracted sample (reached through the 
aqueous upper layer) was directly injected for analysis. The auto-sampler tray was kept at 4 ºC. 
 A binary gradient of (A) 10 mM aqueous ammonium formate solution adjusted to pH 3 with 
formic acid and (B) acetonitrile, at a flow rate of 0.6 mL/min was used. The gradient increased from 
5% A to 40% A in 1.5 min and decreased to 5% A over another 0.5 min (total run time 2 min). MS 
source conditions were as follows: capillary voltage (positive), 4000 V; desolvation gas 
temperature, 300 °C; drying gas flow, 6 L/min; nebulizer pressure, 15 psi. High-purity nitrogen 
(99,999%, Abello-Linde, Spain) was used as collision gas. As nebulizer and drying gas, nitrogen 
was obtained from a central high flow permanent supply using a liquid nitrogen bulk tank (99.5%, 
Praxair, Spain). 
 MS/MS parameters were optimized by injecting 10 μL of 10 ng/mL individual standard 
solutions in dichloromethane using the final chromatographic conditions including column, gradient, 
etc. An automated process using Optimizer for 6400 Series Triple Quadrupole version B.06.00 
from Agilent was used for method development. Confirmation of the final conditions was done by 
repeated injections bracketing the suggested optimal set-up. Fragmentor voltage at 135 V, collision 
energy 20 V and dwell time 100 ms were chosen in all cases. The MRM transitions for 
quantification and identification were respectively m/z 163 to 130 and 117 for nicotine, m/z 167 to 
134 and 121 for nicotine-d4; m/z 177 to 80 and 98 for cotinine and m/z 180 to 80 and 101 for 
cotinine-d3. Data were acquired and processed using MassHunter Quantitative Analysis v B.06.00. 
 
Calibration and quality control samples 
After validation of the equivalence between calibration curves prepared in water versus those 
prepared in each biological matrix, routine calibration curves were prepared in 0.5 mL water 
aliquots as follows:  
 Six point calibration curves were prepared in duplicate containing 1, 100, 500, 1000, 1,500 
and 2,000 ng/mL for nicotine and 0.1, 100, 500, 1000, 1,500 and 2000 ng/mL for cotinine. 




 Quality control samples (low, medium and high QCs) were prepared containing 1.2, 800, 
1,700 ng/mL nicotine and 0.12, 800, 1,700 ng/mL cotinine respectively. QCs were prepared in 
different samples of each matrix all through the validation protocol. Hair samples (10 mg) were 
spiked with the same amount per vial as the 0.5 mL liquid samples. 
 
Method validation in water, urine, oral fluid and hair 
Validation followed a four-assay protocol in line with the current EMEA Guideline on bioanalytical 
method validation [35]. The following parameters were studied: specificity, selectivity, limit of 
detection and quantification, linearity, dilution integrity, precision, accuracy, recovery, carryover, 
matrix effect and short- and long-term stability. The effect of the sample amount was also tested for 
the solid matrix (hair). Calibration curves were prepared in 10 mg hair and 0.5 mL aliquots of water, 
urine and centrifuged oral fluid to cross-validate their equivalence. 
 Specificity was assessed by analysing six blank specimens of each matrix from different 
individuals with and without IS. Selectivity was tested with respect to other nicotine metabolites (i.e. 
nornicotine, norcotinine, 3’-hydroxycotinine, nicotine N-oxide, cotinine N-oxide and 4-hydroxy,4-(3-
pyridyl)-butanoic acid). 
 The limit of detection (LOD) and limit of quantification (LOQ) were calculated as the 
concentrations giving a signal to noise ratio of 3.3:1 and 10:1 respectively. The noise was 
estimated as the standard deviation of the signal (area of analyte divided by area of the IS) 
obtained from all replicates (n=4) of the lowest calibrator (lowest limit of quantification, LLOQ). It 
was verified that the LLOQ had a value above LOQ for all matrices, showing its suitability. 
 Linearity of the method was tested along four assays by calculating the weighted least 
square regression line, using 1/x as the weighting factor. The first assay was performed running 
four replicates at each concentration and curves prepared in each biological matrix. A Dixon test 
was used to test for outliers. The rest of the curves were performed in duplicate. The determination 
coefficient r2 was required to be greater than 0.995 for each analyte. Calibrators were required to 
be within ±15% when calculated against the curve except for the LLOQ for which ±20% was 
allowed. The 95% confidence interval for the difference of both slopes and intercepts were 




approach, calibration samples and QCs prepared in each matrix were back-calculated using the 
calibration curve in water to test for the adequacy of the method. 
 Dilution integrity was tested by spiking blank matrices at double the high QC (i.e. 3,400 
ng/mL) and diluting the sample as needed. For the solid matrix, the effect of sample amount was 
tested by homogenising a hair sample from a smoker and then analysing aliquots 2, 5, 10 or 50 
mg. 
 Within-run precision (repeatability) was expressed as the coefficient of variation (%CV) of the 
calculated concentrations of the five replicates of each quality control sample (n=5) analysed on 
the same batch. Between-run (intermediate) precision was calculated from all replicates of each 
quality control along the 4-day protocol (n=20). 
 Accuracy was calculated as the error, expressed as percent of the nominal concentration 
(%error), obtained for the quality control samples. A maximum deviation of ± 15% from the nominal 
value (20% at the LLOQ) was accepted. 
 Extraction recovery was calculated as the ratio between the mean peak area of the analytes 
obtained from samples spiked before and after extraction (separating and spiking the organic 
phase) [36] using four different matrices at three concentrations. Matrix effect was expressed as 
the ratio between the mean peak area obtained from extracts corresponding to 100% recovery 
(see above) and standard solutions prepared in dichloromethane at the same concentrations. The 
overall recovery (or process efficiency) was calculated by multiplying extraction recovery by matrix 
effect.   
 Carryover was tested by analysing blank samples immediately following spiked samples. To 
rule out any impact on method performance due to the direct injection of the organic phase without 
separation of the upper aqueous phase, 10 consecutive injections of the same sample in each 
matrix were performed. System pressure and full scan profiles were monitored. 
Method-related stability was tested as follows: 
 Short-term (within-run) stability was evaluated along the validation protocol by properly 
distributing QC samples along the sequence of the analytical batches and applying an analysis of 
variance using the area of the analyte as the independent variable, the amount as factor and the 




was used to reject a correlation, therefore proving that samples were stable under within-run 
conditions. 
 Long-term stability was tested by analysing QC samples immediately after preparation or 
after 4 weeks stored at -20ºC. 
 The effect of freeze-thaw cycles (n=3) on the extracted QC samples was tested by analysing 
the extraction vials after submitting them to up to three consecutive freeze-thaw operations (one 




Fig. 1 shows the full product ion spectra of nicotine and cotinine as well as the proposed structure 
of their fragment ions. Structures were elucidated using spectra from isotopically labeled 
analogues and they clarify some discrepancies found in the literature [37-40]. 
 Specificity, or selectivity for endogenous interferences, was tested with six specimens of 
each matrix. No sample exceeded the LOD for the analytes of interest. 
 Selectivity of the assay with respect to other nicotine metabolites was thoroughly tested by 
concurrently analysing them and testing for their retention times, mass spectra and extraction 
recovery. Norcotinine, sharing the same molecular mass of nicotine, was a potential interference. 
However, it eluted right after cotinine (RT = 0.61 min), completely resolved from nicotine. Other 
metabolites did not share the molecular mass of any of the analytes or their retention times. The 
poor extraction efficiency of the most polar metabolites (e.g. 3’hydroxycotinine or 4-hydroxy-4-(3-
pyridyl)-butanoic acid) needs also to be considered in terms of selectivity. 
 Linearity was proven through the whole calibration range and for all matrices with 
determination coefficients (r2) always higher than 0.995. Table 1 shows the results obtained 
including the calculated values of LOD and LOQ. For the sake of comparison, regression 
parameters are given using amount (ng spiked to the aliquot of sample) instead of concentration, 
as it would change between liquid and solid matrices. The confidence intervals (IC95%) of the 




statistically significant (p>0.05). Concentration of calibration samples, as well as quality control 
samples in each matrix prepared through the four validation protocol, were back-calculated using 
the calibration curve in water.  Accuracy (%error) was always below 15% (±20% for calibration 
curves at LLOQ) showing the adequacy of the calibration curve prepared in water. 
 Extraction recovery was above 90% for both analytes in all matrices. The overall process 
efficiency (which will indicate mainly the matrix effect) is summarized in Table 2. Urine gave lower 
results (i.e. around 60%). Oral fluid and hair were in the range 65-90%. These differences were 
well corrected by the IS and had no impact on the LLOQ chosen. Dilution integrity was proven and 
the analysis of increasing amounts (2, 5, 10 or 50 mg) of the same homogeneous non-blank hair 
sample gave a result of 2.6 ± 0.3 ng/mg nicotine and 0.15 ± 0.01 ng/mg cotinine with no statistical 
correlation between individual values and the amount of sample taken for analysis. 
 Within-run and between-run precision, expressed as the CV% of each QC sample 
concurrently analysed on the same batch are given in Table 3. Accuracy, expressed as %error, is 
given in Table 4. Values were consistent with the requirements. 
 Carryover was found to be 0.4% for nicotine and 0.3% for cotinine. These values were also 
obtained when injecting pure standard solutions in dichloromethane, therefore not linked with the 
extraction procedure. Samples were not contaminated as repeated analysis after testing for 
carryover resulted in clean blank samples. The theoretical contribution of the carryover was 
automatically calculated for each sample analysed in a run. When this contribution was higher than 
10% of the calculated concentration, the sample was re-injected. LODs and LOQs are given in 
Table 1. These values proved that the lowest calibrator was well suited as LLOQ for quantification 
of samples of any matrix. 
 The test for within-run stability proved that there was no significant difference in the results 
obtained for the QC samples with respect to the time until analysis and at any of the concentrations 
tested. Long-term stability was also proven with quantitative differences after 1 month at -20ºC 
being within the accuracy tolerance. No statistical difference was found between the results 
obtained when analysing samples after up to three freeze-thaw cycles. 
 The application of the method to the analysis of cotinine in oral fluid collected from a 




concentration of 58±130 ng/mL. Interestingly, the subpopulation that declared being non-exposed 
non-smokers (n=673) showed a mean concentration of 1.7±17 ng/mL, with the highest value being 
19 ng/mL. Those declaring being exposed non-smokers (n=223) had a mean cotinine 
concentration of 2.9±15 ng/mL with the highest value being 160 ng/mL (a value well inside the 
smoker’s range). Nicotine concentrations, not regularly monitored in saliva because of the risk of 
contamination in smokers, were higher in all cases. Urine samples were also analysed in a sub-
group of non-smokers (n=49) with a cotinine mean concentration of 2.2±5.1 ng/mL. 
 Hair samples were also analysed from 629 newborn and children younger than 6 months of 
age with smoking parents. The mean nicotine concentration found was 6.0±9.1 ng/mg with the 
highest being 83 ng/mg (a concentration well inside the range expected for a smoker). Mean 
cotinine concentration was 0.24±0.38 ng/mg. Fig. 2 shows representative chromatograms of the 
analysis of samples from individuals with different levels of exposure to tobacco smoke as well as 




The need for high-throughput methodologies has been fostered by the bioanalytical requirements 
of epidemiological studies [41]. Nicotine and its main metabolite cotinine are the preferred 
biomarkers of environmental tobacco smoke exposure [6], so they were chosen for this work. 
Increasing sensitivity and applicability to different matrices are also requirements imposed by the 
decreasing levels of exposure. 
 Cotinine, and particularly nicotine, are polar compounds that performed well under 
hydrophilic interaction chromatographic conditions. Sensitivity showed to improve by an order of 
magnitude with respect to equivalent reverse phase conditions, under high acetonitrile content and 
the presence of an ammonium buffer. The use of ultra-high performance liquid chromatography 
allowed shortening analysis time down to 2 min. Cotinine and nicotine show proper retention and 
good peak shape: 0.45 min (k=2.1) and 1.46 min (k=6.0) respectively. Extraction was performed in 




the extraction solvent obviating further evaporation steps. Dichloromethane offered multiple 
advantages. Recoveries were excellent under the alkaline and salting-out effect conditions used. 
The HPLC injector needle reached the lower dichloromethane phase through the upper aqueous 
layer without any noticeable impact on background or carryover. It also helped in preventing 
evaporation and extending the stability of extracted samples. 
 Regarding mass spectra of nicotine and cotinine, publications have shown logical differences 
depending on the instrument used. However, the structural elucidation of the fragment ions 
produced lacks some consistency [37-40, 42-44]. The spectrum of nicotine-d4 shows fragments at 
m/z 136 and 134 (analogues to the fragments at m/z 132 and 130 of nicotine-d0) proving that those 
structures cannot be attributed to the frequently described quinoline like cyclizations [38-40]. 
Complementary, spectra obtained for [3’,3’-d2]-nicotine [37] explains the presence of a  double 
bond in position 2´ justifying the structure of its main fragment at m/z 130. In choosing equivalent 
fragments between analytes and IS analogues, the pyridine fragment at m/z 80 shall be avoided 
when using deuterated analogues at that ring, as their corresponding fragment at m/z 84 shares 
the mass with the pyrrolidine ring resulting in an apparent change in behaviour between analyte 
and IS (see Fig. 1). 
 As in previous publications, the method showed good linearity over a wide dynamic range 
[28, 44, 45], making it suitable for the analysis of samples from very different tobacco exposure 
patterns. LOQs were well fit for purpose. Samples showed quantifiable amounts, except for some 
belonging to self-declared non-exposed individuals. Amounts in the range 1-10% of those found in 
exposed individuals have been described as potentially coming from the diet [10]. Those amounts 
are consistent with the LLOQs chosen and samples from real non-exposed individuals resulted in 
non-quantifiable concentrations. Tests performed using a lower dichloromethane volume (250 µL) 
showed to work well, increasing the analyte concentration and improving the LOQ. Selectivity with 
respect to endogenous interferences was proven. However, some blank samples had to be 
discarded as they showed to contain detectable amounts of nicotine and cotinine. Guidelines for 
method validation encourage the use of calibrators and QCs in the matrix to be analysed [35, 46-
49], although they also provide for the possibility of using surrogate matrices when they are difficult 




of calibration curves extracted from water for the quantification of samples in any of the three 
matrices assayed. It simplified and favored the applicability of the method for the analysis of any 
sample. Apart from oral fluid, urine and hair, for which a thorough validation was performed, 
preliminary tests performed in serum and plasma also showed equivalent good results.  
 There is abundant literature on the detection and/or quantification of many other nicotine 
metabolites for different reasons [18, 28, 45]. Many of those metabolites are equally well extracted 
with dichloromethane and can be readily incorporated to the current method. Others, particularly 
those more polar (i.e. 3’-hydroxycotinine, etc.) are poorly extracted from pure dichloromethane. 
Mixtures containing isopropanol have been frequently used either for liquid-liquid or solid-phase 




The quantitative procedure developed minimizes sample preparation steps by extracting the 
samples in the very injection vials. Separation using ultrafast liquid chromatography reduces 
chromatographic time down to 2 min. It is suitable for the analysis of nicotine and cotinine in 
multiple biological matrices (oral fluid, urine and hair) using a common calibration curve extracted 
from water. Due to its proper LLOQs and wide dynamic range, the procedure is well suited for the 
analysis of samples from entire populations, from heavy smokers to subjects with low-level 
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Table 1. Calibration curve parameters (mean ± standard error), limit of detection (LOD) and 
quantification (LOQ) obtained for the analysis of nicotine and cotinine in biological matrices (oral 
fluid, urine and hair) and in water. For comparison, amount of analyte (ng) rather than 
concentration was used for the regression analysis. 






slope y-intercept r2 
Nicotine water 0.046 0.14 0.28 0.1332±0.0008 -0.0049±0.0281 0.9993±0.0794 
 oral fluid 0.079 0.24 0.48 0.1294±0.0011 -0.0043±0.0354 0.9988±0.0099 
 urine 0.050 0.15 0.30 0.1295±0.0016 -0.0085±0.0560 0.9973±0.1582 
 hair 0.086 0.26 0.026 0.1255±0.0011 -0.0105±0.0396 0.9985±0.1120 
Cotinine water 0.0089 0.027 0.054 0.9214±0.0117 0.0155±0.0846 0.9975±0.1070 
 oral fluid 0.0066 0.020 0.040 0.9963±0.0150 0.0091±0.1090 0.9962±0.1379 
 urine 0.0086 0.026 0.052 1.0091±0.0811 0.0029±0.0810 0.9988±0.1731 
 hair 0.0066 0.020 0.0020 0.9311±0.0212 0.0087±0.1676 0.9969±0.2120 





Table 2. Overall recovery (process efficiency) for the analysis of nicotine and cotinine in biological 
matrices (oral fluid, urine and hair) as well as in water (mean ± SD). 
Analyte Matrix Process efficiency (%, N=4) 






 water 82.8±2.8 87.3±5.0 87.4±2.2 
 oral fluid 77.9±2.1 75.9±3.2 76.1±4.0 
 urine 68.2±1.1 67.3±1.3 66.1±0.9 
 hair 70.6±2.5 79.0±5.1 90.2±3.6 






 water 89.5±3.9 106.7±1.9 91.0±1.8 
 oral fluid 65.2±4.0 81.3±6.6 67.8±1.3 
 urine 59.4±3.7 60.4±2.8 58.4±1.6 
 hair 68.7±5.5 82.9±4.4 77.2±0.4 
* For 10 mg hair samples, nicotine concentrations correspond to 0.05, 25 and 100 ng/mg respectively. 





Table 3. Within-run and between-run precision for the analysis of nicotine and cotinine in biological 
matrices (oral fluid, urine and hair) as well as in water expressed as their coefficient of variation 
(CV%). Quantification was performed using calibration curves extracted from water. 
Analyte Matrix within-run (%CV, N=5) between-run (%CV, N=20) 
Nicotine      Low   Medium   High     Low   Medium   High 
 water 4.3 2.2 1.7 8.4 2.8 2.6 
 oral fluid 2.8 1.9 2.7 7.9 1.5 4.9 
 urine 2.8 2.7 3.1 12.1 2.7 3.4 
 hair 5.3 1.7 3.7 5.9 4.3 3.5 
Cotinine      Low   Medium   High     Low   Medium   High 
 water 18.7 3.4 5.0 16.1 5.8 5.5 
 oral fluid 13.0 2.6 6.0 10.3 3.0 6.1 
 urine 5.9 2.6 6.5 17.2 4.9 6.1 





Table 4. Within-run and between-run accuracy for the analysis of nicotine and cotinine in biological 
matrices (oral fluid, urine and hair) as well as in water expressed as the mean % difference of the 
value obtained with respect to the nominal value (%error). Quantification was performed using 
calibration curves extracted from water.  
Analyte Matrix within-run (%error, N=5) between-run (%error, N=20) 
Nicotine  Low Medium High Low Medium High 
 water 3.4 2.0 -1.4 -3.3 2.7 -2.1 
 oral fluid 16.7 0.4 -4.7 10.6 0.6 -2.1 
 urine 7.1 1.3 1.5 11.1 0.0 0.7 
 hair -1.3 4.2 -1.0 4.2 1.5 -0.4 
Cotinine  Low Medium High Low Medium High 
 water -5.5 1.0 -0.3 -8.1 5.0 -2.3 
 oral fluid -6.6 7.3 6.2 -8.2 6.5 3.0 
 urine 0.5 10.1 7.5 9.7 6.7 5.0 







Fig. 1 Product ion mass spectra obtained for nicotine (precursor ion [M+H]+  at m/z 163), cotinine 
(precursor ion [M+H]+ at m/z 177) and their corresponding deuterated analogues used as internal 





Fig. 2 Representative chromatograms corresponding to the analysis of samples of a non-exposed 
non-smoker, an exposed non-smoker and a regular smoker analysed as well as calibration and 
quality control samples extracted from water 
 
